Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry

  • Gerrit FrommeyerEmail author
  • Dietrich Andresen
  • Hüseyin Ince
  • Sebastian Maier
  • Christoph Stellbrink
  • Thomas Kleemann
  • Karlheinz Seidl
  • Ellen Hoffmann
  • Bernhard Zrenner
  • Matthias Hochadel
  • Jochen Senges
  • Lars Eckardt
Original Article


According to current guidelines prophylactic implantable cardioverter-defibrillator (ICD) therapy is recommended in patients with significantly impaired left ventricular systolic function. However, the recently published DANISH trial did not find a significantly lower long-term rate of death from any cause compared with usual clinical care in patients with non-ischemic cardiomyopathy. We investigated whether registry data from a multi-center ‘real-life’ registry on patients with non-ischemic cardiomyopathy are similar to this trial. The German Device Registry (DEVICE) is a nationwide, prospective registry with one-year follow-up investigating 5451 patients receiving device implantations in 50 German centers. The present analysis of DEVICE focused on patients with non-ischemic cardiomyopathy and a left ventricular ejection fraction ≤35% who received a prophylactic ICD. Out of 779 patients with symptomatic heart failure and nonischemic cardiomyopathy, 33.1% received a single chamber ICD (VVI), while 11.0% were implanted with a dual-chamber ICD (DDD), and 55.8% received a defibrillator system for cardiac resynchronization therapy. Median follow-up was 16.1 months. 90.7% were alive at follow-up, 9.3% had died during this period. Overall mortality after one year was 5.4%. Overall mortality one year after implantation was significantly increased in patients 68 years and older(7.9%) as compared to younger patients (59–68 years: 2.5%; < 59 years: 3.8%; p < 0.015). Data from the present registry support the recently published results of the DANISH trial. In particular the influence of an increased age as proven in the DANISH trial might also play a role in the present collective. This limits the potential beneficial effect of ICD therapy in particular in the elderly population.


Non-ischemic cardiomyopathy ICD implantation Sudden cardiac death Age-dependent effects 


Compliance with ethical standards

Conflict of interest

Karlheinz Seidl reported lecture honoraria from Medtronic and St. Jude Medical. All other authors declared no conflict of interest related to this study.


  1. 1.
    Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 esc guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRefPubMedGoogle Scholar
  2. 2.
    Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 335:1933–1940CrossRefPubMedGoogle Scholar
  3. 3.
    Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMedGoogle Scholar
  4. 4.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237CrossRefPubMedGoogle Scholar
  5. 5.
    Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (cat). Circulation 105:1453–1458CrossRefPubMedGoogle Scholar
  6. 6.
    Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, AMIOVIRT Investigators (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia–amiovirt. J Am Coll Cardiol 41:1707–1712CrossRefPubMedGoogle Scholar
  7. 7.
    Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation Investigators (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158CrossRefPubMedGoogle Scholar
  8. 8.
    Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjaer H, Brandes A, Thogersen AM, Gustafsson F, Egstrup K, Videbaek R, Hassager C, Svendsen JH, Hofsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230CrossRefPubMedGoogle Scholar
  9. 9.
    Haugaa KH, Tilz R, Boveda S, Dobreanu D, Sciaraffia E, Mansourati J, Papiashvili G, Dagres N (2017) Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-danish trial era: results of the European heart rhythm association survey. Europace 19:660–664CrossRefPubMedGoogle Scholar
  10. 10.
    Kobe J, Andresen D, Maier S, Stellbrink C, Kleemann T, Gonska BD, Reif S, Hochadel M, Senges J, Eckardt L (2017) Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age—insights from the German device registry. Int J Cardiol 228:784–789CrossRefPubMedGoogle Scholar
  11. 11.
    Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP (2017) Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials. Eur Heart J 38:1738–1746CrossRefPubMedGoogle Scholar
  12. 12.
    Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B, Furnkranz A, Makimoto H, Kelm M, Schulze V (2017) Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-danish: an updated meta-analysis and systematic review of randomized controlled trials. Clin Res Cardiol 106:501–513CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  • Gerrit Frommeyer
    • 1
    return OK on get
  • Dietrich Andresen
    • 2
  • Hüseyin Ince
    • 3
    • 4
  • Sebastian Maier
    • 5
  • Christoph Stellbrink
    • 6
  • Thomas Kleemann
    • 7
  • Karlheinz Seidl
    • 8
  • Ellen Hoffmann
    • 9
  • Bernhard Zrenner
    • 10
  • Matthias Hochadel
    • 11
  • Jochen Senges
    • 11
  • Lars Eckardt
    • 1
  1. 1.Division of Electrophysiology, Department of Cardiovascular MedicineUniversity of MünsterMünsterGermany
  2. 2.Department of CardiologyKardiologie Am Hubertus-KrankenhausBerlinGermany
  3. 3.Department of CardiologyVivantes Klinikum Am Urban Und Im FriedrichshainBerlinGermany
  4. 4.Universitätsmedizin RostockRostockGermany
  5. 5.Department of CardiologyKlinikum StraubingStraubingGermany
  6. 6.Department of CardiologyKlinikum BielefeldBielefeldGermany
  7. 7.Department of CardiologyKlinikum LudwigshafenLudwigshafenGermany
  8. 8.Department of CardiologyKlinikum IngolstadtIngolstadtGermany
  9. 9.Department of CardiologyHeart Center Munich-BogenhausenMunichGermany
  10. 10.Department of CardiologyKrankenhaus Landshut-AchdorfLandshutGermany
  11. 11.Stiftung Institut für Herzinfarktforschung (IHF)LudwigshafenGermany

Personalised recommendations